Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells
- PMID: 26815508
- DOI: 10.1007/s13277-016-4881-9
Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells
Abstract
The WT1 gene is an important oncogene, and its overexpression is considered as an effective target for anticancer therapy. Regulation of its gene transcription is one way for WT1-targeting drug design. Recently, in silico analysis of some oncogene promoters like WT1 showed some guanine-rich regions with the ability to form G-quadruplex structures. Ligands like 5,10,15,20-tetra(N-methyl-4-pyridyl)-porphine (TMPyP4) have predominant effect on G-quadruplex stabilization. The aim of this study was to understand the effect of TMPyP4 on WT1 gene transcription via stabilization of promoter G-quadruplexes. We examined the formation of new G-quadruplex motifs in WT1 promoter in the presence of TMPyP4. In order to understand the nature of its interaction with WT1 promoter quadruplexes, differential pulse voltammetry (DPV), circular dichroism (CD), polyacrylamide gel electrophoresis, electrophoretic mobility shift assay (EMSA), polymerase chain reaction (PCR) stop assays, and quantitative RT-PCR were performed. According to the results, the WT1 promoter can form stable intramolecular parallel G-quadruplexes. In addition, after 48 and 96 h of incubation, 100 μM TMPyP4 reduced the WT1 transcription to 9 and 0.4 %, respectively, compare to control. We report that ligand-mediated stabilization of G-quadruplexes within the WT1 promoter can silence WT1 expression. This study might offer the basis for the reasonable design and improvement of new porphyrin derivatives as effective anti-leukemia agents for cancer therapy.
Keywords: Downregulation of transcription; G-quadruplex stability; TMPyP4; WT1 promoter.
Similar articles
-
G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs.J Biosci. 2019 Mar;44(1):12. J Biosci. 2019. PMID: 30837363
-
The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents.Mol Cancer Ther. 2008 Apr;7(4):880-9. doi: 10.1158/1535-7163.MCT-07-2119. Mol Cancer Ther. 2008. PMID: 18413801 Free PMC article.
-
Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4.Nucleic Acids Res. 2007;35(22):7698-713. doi: 10.1093/nar/gkm538. Epub 2007 Nov 5. Nucleic Acids Res. 2007. PMID: 17984069 Free PMC article.
-
G-quadruplex structures in the human genome as novel therapeutic targets.Molecules. 2013 Oct 8;18(10):12368-95. doi: 10.3390/molecules181012368. Molecules. 2013. PMID: 24108400 Free PMC article. Review.
-
Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules.Curr Med Chem. 2017;24(42):4873-4904. doi: 10.2174/0929867323666160829145055. Curr Med Chem. 2017. PMID: 27573064 Review.
Cited by
-
G-quadruplexes: a promising target for cancer therapy.Mol Cancer. 2021 Feb 25;20(1):40. doi: 10.1186/s12943-021-01328-4. Mol Cancer. 2021. PMID: 33632214 Free PMC article. Review.
-
G-quadruplex structural variations in human genome associated with single-nucleotide variations and their impact on gene activity.Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2013230118. doi: 10.1073/pnas.2013230118. Proc Natl Acad Sci U S A. 2021. PMID: 34001600 Free PMC article.
-
Nucleophosmin in Its Interaction with Ligands.Int J Mol Sci. 2020 Jul 10;21(14):4885. doi: 10.3390/ijms21144885. Int J Mol Sci. 2020. PMID: 32664415 Free PMC article. Review.
-
shRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung Metastases In Vitro and In Vivo.In Vivo. 2019 May-Jun;33(3):777-785. doi: 10.21873/invivo.11539. In Vivo. 2019. PMID: 31028197 Free PMC article.
-
G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs.J Biosci. 2019 Mar;44(1):12. J Biosci. 2019. PMID: 30837363
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources